בריאות · סיקור מלא

Hadassah Hospital Pioneers Alpha Radiation Treatment for Recurrent Glioblastoma in Israel

איך 5 חדרי חדשות ישראליים סיפרו את הסיפור הזה, זה לצד זה.

Hadassah Hospital Pioneers Alpha Radiation Treatment for Recurrent Glioblastoma in Israel
60% right-leaning
Center 2Right 3

מאת יעל אנקר

דווח לראשונה בMako · Aug 12, 2026

מה קרה

Hadassah Medical Center in Jerusalem has initiated Israel's first clinical trial using alpha radiation implanted directly into recurrent glioblastoma tumors. The innovative treatment aims to target tumors precisely while sparing healthy brain tissue. This Phase I trial assesses safety and feasibility, offering new hope for patients with limited options after standard therapies fail.

  • 01Hadassah Medical Center performs Israel's first alpha radiation treatment for recurrent glioblastoma.
  • 02Tiny alpha radiation sources are implanted directly into the tumor using precise neurosurgical navigation.
  • 03The treatment aims to minimize damage to healthy brain tissue while targeting the tumor effectively.
  • 04Glioblastoma is the most common malignant brain tumor in adults with poor prognosis after recurrence.
  • 05The Phase I trial focuses on safety and feasibility before assessing treatment effectiveness.
  • 06Plans exist to expand the trial to patients with brain metastases lacking other treatment options.

התקציר תורגם וסוכם מהמקורות למטה על ידי baba. לקריאה המלאה פתחו כל מקור.

סיקור מלא · 5 מקורות

אותו אירוע, כפי שכל חדר חדשות דיווח עליו בנפרד. פתחו כמה כדי להשוות במה כל אחד מדגיש ומה הוא משמיט.

סיפורים קשורים

Ashdod Hospital Launches First Brachytherapy Unit in Southern Israel for Cancer PatientsAug 18, 2026New Targeted Therapies Revolutionize Breast Cancer Treatment and Survival in IsraelJul 5, 2026Israeli Biomed Firm Alpha Tau Medical Plans Dual Listing on Tel Aviv Stock ExchangeAug 10, 2026Israeli Hospital Performs Breakthrough Brain Surgery to Relieve Man's 40-Year Cluster HeadachesAug 13, 2026Israeli Hospital Introduces Groundbreaking Surgical Treatment for Debilitating Cluster HeadachesAug 16, 2026Israeli Patient’s Advanced Prostate Cancer Disappears After Lutetium-177 TreatmentAug 4, 2026